St. Jude researchers analyzed second neoplasms from 160 survivors and discovered that pediatric chemotherapy and radiation treatments leave distinct DNA mutation “fingerprints” linked to later development of secondary cancers. (IMAGE)

St. Jude Children's Research Hospital

St. Jude researchers analyzed second neoplasms from 160 survivors and discovered that pediatric chemotherapy and radiation treatments leave distinct DNA mutation “fingerprints” linked to later development of secondary cancers.

Caption

First and corresponding author Samuel Brady, PhD, St. Jude Department of Pharmacy & Pharmaceutical Sciences.

Credit

Courtesy of St. Jude Children's Research Hospital

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.